An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT07365332 · RECRUITING
Trial details
- NCT number
- NCT07365332
- Sponsor
- Inhibikase Therapeutics
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-23
- Primary completion
- 2029-06-01
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.